Abstract
Crosstalk between tumor infiltrating macrophages and tumor cells is thought to play an indispensable role in oral squamous cell carcinomas (OSCC) by induction and maintenance of tolerance microenvironment. High infiltration of M2 macrophages and increasing expression of Kinesin family member 4A (Kif4A) in primary OSCC have been proved to correlate with greater tumoral size and poor clinical outcome. However, linkage between Kif4A and infiltrating macrophages in tumorigenesis and progression remains unclear. In the present study, we show that, the interaction between THP-1derived macrophage and OSCC cell line Cal-27 may up-regulate the Kif4A expression in both of them. Additionally, elevated soluble CCL2 in medium and more expression of CCR2 on macrophage were observed during the crosstalk. SiRNA of Kif4A and neutralizing antibody of CCL2 were utilized to identify that; increasing Kif4A can promote the recruitment of macrophages towards Cal-27 and educate them to M2 polarized macrophages via regulating CCL2/CCR2. In combination, the results of the present study may provide interesting clues to understanding the Kif4A-CCL2/CCR2-macrophage axis as a novel therapeutic target to improve the clinical outcome of OSCC.
Introduction
Oral squamous cell carcinoma (OSCC), being a major part of head and neck squamous cell carcinoma (HNSCC), accounts for almost 90% of all oral malignancies1, 2. Despite previous researches have made tremendous efforts to improve in the field of surgery, radiotherapy and chemotherapy, the mortality rates failed to descend substantially. Growing study suggests that tumor-immunological parameters in the prognostic classification and treatment of OSCC should be considerate sufficiently3, 4. As a kind of high-plastic immunocyte, macrophages constitute a major component of leukocytes in almost all types of malignancy including OSCC. It responds to the stimulator in varied tumor microenvironments and be polarized with the release of a far-ranging of cytokines, chemokines and enzymes that mediate cancer cells invasion into surrounding normal tissues, and metastasis to local or distant sites5. Accumulating evidences indicate a close association of alternative polarization of macrophages (M2) with an increased dedifferentiation and poor cancer outcome, which can already be detected in the initial biopsies in early stage of OSCC6, 7. Thus, the mechanisms of macrophages recruitment at the tumor sites and interaction with cancer cells are gaining increasing attention in the OSCC progression. But the process how OSCC cells attract macrophages and polarize them with an immune tolerance feature remains incompletely understood.
A possible candidate for this role is represented by chemokine C-C motif ligand (CCL2), which has been found in many kinds of cancer tissue samples and function as a crucial mediator in promoting tumorigenesis and metastasis8, 9. Besides its capacity to inducing the recruitment of monocytes/macrophages via binding to the receptor CCR2, our previous study and many others’ have proved that elevated CCL2 contributes to the establishment of immunotolerance microenvironment via educating monocytes/macrophages to possess immunosuppressive function and stimulating T lymphocytes polarized towards TH2 cells10, 11. The versatile roles of CCL2 in both promotion of tumor progression/metastasis and education of immunocyte make the CCL2-signaling a dramatic therapeutic target for tumor treatment. Although there is a large body of evidence supporting CCL2 plays a crucial and positive regulatory role in tumorigenesis, the mechanism of their regulation in OSCC has not been fully investigated.
Kinesin superfamily (Kif) member Kif4A, is a microtubule-based motor protein that fulfill its essential role in intracellular anterograde transport and cell division12. It has been reported that Kif4A has close association with activation of immunocyte13, and our former microarray study has found a decreased expression of CCL2 and CCR2 in mouse’s macrophage cell line when Kif4A is silencing (unpublished). It is absent or present at very low level in most adult normal tissues, however, cDNA microarray study and histochemical analysis reveal that there is an over-expression of Kif4A mRNA in human cervical cancer and it might be a prognostic biomarker and a possible therapeutic target for lung cancer14, 15. Notably, there is also an elevated expression of Kif4A in OSCC and it was speculated to be a key regulator for tumoral progression of human oral cancer16.
Owing to above observations, we postulate that there would be a possible link between aberrant change of Kif4A and induction of recruited macrophages which contribute to the generation of immunotolerant tumor microenvironment. However, to the best of our knowledge, there are no definitive experiments showing that increasing Kif4A has an effort on educating immunocyte, especially macrophage, in OSCC. Therefore, the aim of resent study is to assess whether Kif4A might recruit macrophage and modulate it towards an immune tolerance feature by CCL2-signaling in OSCC.
Results
Both Kif4A and CCR2 are increased in THP-1 derived macrophages via co-culturing with OSCC
To assess the expression and function of Kif4A in OSCC and mimic the crosstalk between macrophages and OSCC cells in the tumor microenvironment, we employed an in vitro two-chamber transwell co-culture system that allows the interaction between infiltrating macrophages and OSCC cells in the existence or absence of Kif4A silencing. Consistent with recent findings in vivo 16, Cal-27, a kind of OSCC cell line, expressed Kif4A in a high level (Fig. 1a). Then, we performed western blot analysis of Kif4A expression of Cal-27 and monocyte cell lines, THP-1-derived macrophages in co-culture system after 24 hours culturing. As shown in Fig. 1a, there was no obviously change of Kif4A that can be detected in Cal-27 between co-culture system and monocultures group. On the contrary, compared with the monoculture group, co-culturing with Cal-27 cells significantly increased Kif4A expression in THP-1-derived macrophages (Fig. 1b). Furthermore, we detected the relationship between Kif4A and macrophage in OSCC tissue by immunohistochemistry. As the same with our observation in co-culture system, the expression of Kif4A in OSCC tumor cells was at a high level and tumor-infiltrating macrophages express Kif4A at a middle level (as shown in the black arrow). However, we cannot detect Kif4A expressing macrophage in pericarcinous tissue (see Supplementary Fig. S1).
Then, we silenced Kif4A function via liposome Kif4A-siRNA (siKif4A) and used scramble RNA (scr) as a control. As shown in Fig. 1a and b, siKif4A can blockaded the expression of Kif4A in both Cal-27 and THP-1-derived macrophages efficiently.
To study the functional role of Kif4A, we analyzed CCR2 expression of Cal-27 and THP-1-derived macrophages in co-culture system with siKif4A or scr after 24 hours culturing. Western blot analysis showed that, CCR2 of THP-1-derived macrophages was significantly up-regulated in the presence of Cal-27. However, knockdown of Kif4A expression of macrophages in co-culture system with siKif4A was able to significantly reduce the increased level of CCR2 of macrophages (Fig. 1d). Conversely, CCR2 maintained in a very low level and no different expression was detected in Cal-27 of all groups (Fig. 1c). We also evaluated expression of CCR2 on the surface of THP-1-derived macrophage by flow cytometry. Similar results as described above by western blot analysis were observed, CCR2 level on the surface of THP-1-derived macrophage was promoted when co-cultured with Cal-27, which can also be reduced when knockdown of Kif4A expression of macrophages by siKif4A (Fig. 1e). However, we failed to detect knockdown Kif4A expression of Cal27 in co-culture system have significantly effect on the expression level of CCR2 on the surface of macrophages as compare with it from co-culture system without any treatment. Our results demonstrate that Kif4A of macrophages will be significantly up-regulated during co-culturing with OSCC cells; it may also involve in specific activation of the CCR2 of macrophages.
Blockade of Kif4A ablates the significant expression of CCL2 in co-culture system
CCL2 was thought to be the strongest ligand for CCR2, which may enhance tumors growth/metastasis in vivo by increasing the recruitment of macrophages and angiogenesis. More importantly, our group and others had proved that secretion factors including CCL2, vascular endothelial growth factor (VEGF), trans-forming growth factor-β (TGF-β), have been implicated as being important cell co-culture regulators. Then we investigated whether this co-culture system could affect the expression of CCL2, and whether Kif4A was also involved in this progress. After co-cultured for 24 hours, two chambers’ cells were separated and cultured alone in 2 mL fresh medium for another 24 h, supernatant was collected and CCL2 concentration was analyzed by ELISA. Results showed that secreted levels of CCL2 were remarkable elevated in both Cal-27 cells and THP-1-derived macrophage when co-cultured with each other compared with cells monoculture groups (Fig. 2a). When we treated Cal-27 cells or THP-1-derived macrophage with siKif4A, it dramatically prevented the up-regulation of CCL2, especially in the Cal-27 chambers of co-culture system (Fig. 2a). We undertook to further identify the source of co-culture-produced CCL2. To do so, we carried out quantitative real-time PCR (RTQ-PCR) and found CCL2 expression levels in both THP-1-derived macrophage and Cal-27 were increased during co-culture with each other (Fig. 2b). As expected, we found targeting Kif4A with siRNA in both THP-1-derived macrophage and Cal-27 were significantly reduced the up-regulated expression of CCL2 (Fig. 2b).
To test if this raise was associated with the ratio of macrophages to cancer cells, Cal-27 cells were co-cultured with increasing amounts of THP-1-derived macrophages. Cells were collected after 24 hours co-culture and the RTQ-PCR results showed that, transcription level of CCL2 of Cal-27 cells increased to the peak at 1:1 ratio of macrophages to cancer cells and started to decrease at 1:2 ratio. In contrast, no marked change of CCL2 transcription was found in THP-1-derived macrophages at any co-culture ratio (Fig. 2c). Next, we examined the dynamic change of secreted levels of CCL2 in different time points at 1:1 ratio of macrophages to cancer cells. We found that secretion rate of CCL2 in co-culture system became increasing after 6 hours and it was increased to about 4000 pg/mL after 24 hours, then the secretion rate slowed down (Fig. 2d). Given that CCL7 was another important ligand of CCR2, we determined whether co-culture system or Kif4A was also involved in regulation of this chemokine ligand. We observed that neither co-culture system nor Kif4A had obviously effected on the regulation of CCL7 (Fig. 2e).
Co-culture system enhanced migration of the macrophage via Kif4A-CCL2 induction
CCR2 and its ligand CCL2 were a couple of chemotactic factors which played an important role in recruitment of macrophage17. In order to extend our findings with the link of Kif4A to CCR2 and CCL2, we then set out to identify recruitment effect of Kif4A on macrophages. We performed transwell assays by a two-chamber migration system, in which, THP-1-derived macrophages and Cal-27 were separated by an 8 μm pore membrane. After 24 hours, remarkable increased numbers of THP-1-derived macrophages migrated toward Cal-27 cells in the lower chamber, as compared with the lower chamber containing medium alone (Fig. 3a right). But, there was little effect on Cal-27 cells recruitment during co-culture as compared with the lower chamber containing medium alone (Fig. 3a left). We hypothesized that up-regulation of CCR2 and CCL2 is capable of stimulating chemotaxis of macrophages, since we observed robustly elevated CCL2 level in co-culture system and increased expression of CCR2 in THP-1-derived macrophages. In support of this hypothesis, we assessed the effect of CCL2 neutralization on macrophages migration in co-culture system. Anti-CCL2 neutralizing mAb (10 μg/mL) and the isotype antibody (10 μg/mL) were added to medium in the lower chamber of two-chamber migration system before the transwell assay. As shown in Fig. 3b, the addition of anti-CCL2 neutralizing mAb, but not isotype control, significantly prevented the up-regulation of macrophages migration.
Next, we investigated whether Kif4A silencing-induced decreased of secreting CCL2 in supernatant and expression of CCR2 on THP-1-derived macrophages may also effect the capable of macrophages migration. As we expected, the migration of macrophages was dramatically decreased with siKif4A treated THP-1-derived macrophages, as compared with scramble treated THP-1-derived macrophages in two-chamber migration system (Fig. 3c). Similarly, targeting Kif4A with siKif4A in Cal-27 cells of co-culture system also significantly reduced the migration of macrophages as compared with scr treated Cal-27 cells in co-culture system (Fig. 3d). In order to exclude the influence of lipofectamine on the results, we also compared cells migration without any treatment group (Fig. 3a right) with scr treated THP-1-derived macrophages group (Fig. 3c left) both in co-culture system. We observed similar cells migration ability between them, it suggested lipofectamine has no obvious influence on the cells migration in our co-culture system. Therefore, these results clearly showed that Kif4A mediated recruitment of macrophage in co-culture system via regulate secretion of CCL2 in both Cal-27 cells and THP-1-derived macrophages and expression of CCR2 on macrophages.
Kif4A-CCL2 modulated THP-1-derived macrophages towards M2-type cytokine profile
Macrophages infiltrated in tumor were considered as polarized M2 macrophages population in most mouse and human tumors5. Our next objective was to ascertain whether co-culture system could modulate the cytokines expression of THP-1-derived macrophages towards M2-type profile. For this purpose the two-chamber co-culture system was used, where THP-1-derived macrophages were localized in the lower chamber and Cal-27 cells to the upper chamber. We tested the transcription of M1-type cytokines (TNF-α, IL-1β, IL-6 and IL-12p40) and M2-type cytokines (TGF-β, IL-4 and IL-10) by RTQ-PCR. As shown in Fig. 4a, transcription of most M1-type cytokines were enhanced but all M2-type cytokines’ were reduced in macrophages when siKif4A treated THP-1-derived macrophages in co-culture system as compared with scr treated. Moreover, when we treated Cal-27 cells in the upper chamber THP-1-derived macrophages of co-culture system with siKif4A or scr, the similar results were observed (Fig. 4b).
To explore the potential role of CCL2 in the experimental setting used in the present study, and further identify Kif4A modulated THP-1-derived macrophages towards M2-type cytokine profile via regulate the expression of CCL2, the above-mentioned experiments were performed with addition of neutralizing mAb (10 μg/mL) or the isotype antibody (10 μg/mL) to the co-culture system. As expected, when CCL2 was neutralized, transcriptions of M1-type cytokines were enhanced and M2-type cytokines’ were reduced in macrophages as compared with isotype antibody treated co-culture system (Fig. 4c).
Taken together, the cytokine profile analysis suggested, Kif4A not only take part in mediating migration of macrophages, but also involve in regulating macrophages towards M2-type. Both these processes were achieved by regulate expression of CCL2.
Kif4A-CCL2 promoted expression of suppressive molecules of THP-1-derived macrophages via STAT3 signaling
THP-1 is an acute monocytic leukemia cell line, which belongs to human myelomonocytic cells. Our previous study showed that, CCL2 was involved in the induction of candidate suppressive molecules of myelomonocytic cell-derived MDSCs10. On the basis of this result, we hypothesized that Kif4A could also induce THP-1-derived macrophages with suppressor cells’ features upon CCL2. As we expected, co-cultured with Cal-27 could significantly improved suppressive molecules of myelomonocytic cell-derived MDSCs, such as ARG-1, COX2, IDO1 and IL-4Rα in THP-1-derived macrophages (Fig. 5a). Whereas, treated THP-1-derived macrophages with siKif4A would reduce the increased level of ARG-1, COX2 and IL-4Rα in macrophages prominently (Fig. 5a). Similar results were observed when we treated Cal-27 cells in the upper chamber with siKif4A (Fig. 5b).
To further confirm whether Kif4A exerts the effect on promoting expression of candidate suppressive molecules of myelomonocytic cell-derived MDSCs via CCL2 signaling, CCL2 was neutralized at the beginning of co-culture. RTQ-PCR analysis showed that, expression of ARG-1, COX2 and IL-4Rα in THP-1-derived macrophages were significantly inhibited (Fig. 5c). We had proved that, CCL2 regulated expression of suppressive molecules of myelomonocytic cells via STAT3 signaling partially10. According to this result, we speculated that, Kif4A was an upstream signal that promoted STAT3 induction upon CCL2 in co-culture system. For this purpose, the effect of Kif4A on CCL2-STAT3 pathway was detected through western blot analysis. As showed in Fig. 5d, there was a statistically higher STAT3 protein expression in THP-1-derived macrophages from co-culture system as compared with monoculture group. This effect was abolished by treatment with a siKif4A on THP-1-derived macrophages (Fig. 5d).
Taken together, these findings support our hypothesis that Kif4A was an upstream signal that could induce THP-1-derived macrophages with myelomonocytic cell-derived MDSCs’ features upon CCL2.
Discussion
In the current study, we utilized a two-chamber co-culture system to partly mimic the crosstalk between cancer cells and macrophages in OSCC tissue. The results provided experimental evidences that a remarkable interaction may occur between them, which gave rise to increasing expression of Kif4A in both two types of cells and elevated CCL2 level in supernatant. In addition, we identified the up-regulated expression of CCR2 on macrophages and high concentration of CCL2, which, in turn, promoted recruitment and polarization of macrophages, could be modulated by Kif4A.
Kinesin superfamily (Kif) constitute a group of microtubule-based motor proteins with 45 members that exhibit diverse functions, including the transport of vesicles, organelles, chromosomes, protein complexes, and so on18, 19. Several studies have identified that Kifs have intimate connection with the genesis and progression of many tumors12. Among them, Kif4A is significantly up-regulated in OSCC, cervical and lung cancers, whereas it is down-regulated in gastric cancers14–16, 20. In line with above research in vivo, we find a high level expression of Kif4A in OSCC cell line from current study (Fig. 1a). Many reports suggested that overexpression of Kif4A is closely related to tumor size and has positive correlation with cancer proliferation and carcinogenesis15, 16. To the contrary, some study has reported that loss of Kif4A leads to tumor formation and acts as a primary trigger of tumorigenesis and overexpression of it inhibits proliferation of carcinoma cells in vitro and in vivo 21, 22. Owing to these conflicting results, more efforts are called for to better understand the complex roles Kif4A plays in different cancers development and progression.
Growing body of evidences indicates that the crosstalk between tumor cells and infiltrated macrophages determines the immune status of tumor microenvironment, which is closely correlated with tumor development and progression and clinical outcomes of OSCC patients23, 24. However, the interaction between tumor cells and infiltrated macrophages and the induction of macrophages towards M2 in OSCC has not been elucidated clearly. The current two-chamber transwell co-culture study shows there is a remarkable increased Kif4A expression in macrophages in response to OSCC cells (Fig. 1b). Recently, an association has been demonstrated between Kif4A and T-cell activation in the idiopathic inflammatory myopathies13. Notably, our unpublished results also find targeting Kif4A with siRNA in RAW264.7, a mouse macrophage cell line, might affect its phenotype and cytokines profile. Numerous studies indicate that polarization of immunocyte, including T-cell and macrophage, play an irreplaceable role in the establishment of tumor environment and usually associate with tumor outcome25, 26. It is well accepted that, during polarization of macrophage, there are significant changes in the cellular structure involving reorientation of cytoskeleton and microtubule-organizing centers, which mediate by motor proteins. All these considerations indicate that, Kifs are most likely to participate in the process of macrophages polarization especially during the interaction with cancer cells. The findings from present study indicate that Kif4A play a positive role in shifting macrophage polarization towards M2 polarized cells in OSCC microenvironment. To our knowledge, it is the first study demonstrating that Kif4A is involved in the operation of macrophage polarization.
Amounts of studies have proved CCL2 expression in numerous kinds of tumor including prostate, breast, lung, melanoma, ovary and multiple myeloma8, 27, 28. In agreement with these findings from the tumor microenvironment, crosstalk between macrophages and OSCC cells may accelerate the production of CCL2 in co-culture system (Fig. 2a). More importantly, we observe that, expression of CCL2 in both two types’ cells is significantly inhibited upon Kif4A silencing via siRNA, suggesting a potential modulatory-supportive role of this motor protein in establishment of tumor microenvironment in OSCC. Being an important couple of chemokines, CCL2 mediate macrophages migration via binding CCR2. Several cancer cell lines, which express CCR2, shift their proliferation and invasion capability in response to CCL2, indicating the presence of CCR2 as a functional receptor29, 30. In the data presented here, an elevated CCR2 level in macrophages from co-culture system is found and associate with Kif4A partly. Our current study verifies a previously unrecognized novel role of Kif4A in positively regulating CCL2 expression and promoting macrophages migration toward OSCC cells. Moreover, no CCR2 can be detected in OSCC cell line, suggesting CCL2 might not operate OSCC progression via CCL2-CCR2 axis directly.
Recent exertion has brought new light on education of immunocyte, which connects CCL2 with the establishment of tolerant microenvironment10, 11, 17, 28. Besides the dramatic chemotaxis of CCL2, it has been proved to control T cells polarize towards TH2 cells with an up-regulated secretion of TH2 cytokine11. Furthermore, our previous study also demonstrates that, CCL2 plays a substantial role in the induction CD14+ myeloid-derived suppressor cells (MDSCs), and promotes a tolerogenic immune response10. CD14+ MDSCs with powerful immunosuppressive activity are first found in squamous cell carcinoma of the head and neck31. Both CD14+ MDSCs and tumor infiltrated macrophage differentiate from CD14+ myelomonocytic cells, with similar function in tumor environment. Our results prove that, Kif4A-CCL2 axis is involved in the promotion of macrophage polarization towards M2 (Fig. 4c) and up-regulation of several key suppressive molecules, including ARG1, COX2, and IL4Rα (Fig. 5), during interaction between macrophages and OSCC cells. These results might give an explanation why overexpressed Kif4A in OSCC correlated with poor clinical outcome.
Taken together, our current research provide substantial clues to better understand the mechanism that might involved in the induction and maintenance of tolerant microenvironment in OSCC. We identify the Kif4A-CCL2/CCR2-macrophage axis as a feasible new target to improve the clinical outcome of OSCC. However, the precise regulatory mechanisms of Kif4A-CCL2/CCR2-macrophage axis in this context have not been elucidated completely. Further investigations are still called for to obtain the panorama of the immunologic functions of Kif4A-CCL2/CCR2-macrophage axis in OSCC tissue.
Materials and Methods
Reagents and antibodies
For western blot analysis, the rabbit polyclonal to Kif4A was obtained from Abacm (Cambridge, UK), mouse anti-human CCR2 mAb was from Novus Biologicals (Littleton, CO, USA), rabbit anti-human mAb STAT3, anti-human mAb phosphor-STAT3 were from Cell Signaling Technology (Boston, MA, USA), mouse anti-human β-actin mAb and mouse anti-human GADPH mAb were purchased from Cell Signaling Technology (Beverly, MA, USA). The fluorescently conjugated anti-human mAbs CCR2-PE and the isotype antibody for flow cytometry analysis were obtained from Becton-Dickinson Biosciences (San Diego, CA, USA). Mouse anti-human CCL2 neutralizing antibody and isotype antibodies were purchased from R&D Systems (Minneapolis, MN, USA).
Cell culture and generation of THP-1-derived macrophages
Cal-27 (human OSCC cell line) and THP-1 (human acute monocytic leukemia cell line) were obtained from the American Type Culture Collection (ATCC). Cells were maintained in complete RPMI-1640 medium (Gibco-Invitrogen, Carlsbad, CA, USA) with 10% fetal bovine serum (FBS, Gibco-Invitrogen, Carlsbad, CA, USA), 100 U/mL penicillin and 100 μg/mL streptomycin. All cells were cultured at 37 °C in a humidified 5% CO2 and 95% air environment. To generate THP-1-derived macrophages, 1 × 106 THP-1 cells were treated with 100 ng/mL PMA for 48 h32 and adherent cells were collected for further research.
Co-culture system studies
Cal-27 cells were seeded (2 mL/well, 1 × 105/mL) into wells of a 6-well cell tissue culture plate (BD Biosciences; Franklin Lakes, NJ, USA) in RPMI-1640 medium with 10% FBS and allowed to attach overnight. Then medium was replaced by 2 mL pre-warmed fresh RPMI-1640 medium with 10% FBS, and THP-1-derived macrophages (1 mL/well, 2 × 105/mL) were seeded into the upper 0.4 μm transwell chamber (BD Biosciences; Franklin Lakes, NJ, USA). Cal-27 cells and THP-1-derived macrophages were cultured alone in 6-well plate (2 mL, 2 × 105/mL) fresh medium as monocultures control groups. In some co-culture experiments, as shown in Fig. 1c and d, THP-1-derived macrophages were seeded at different density or co-cultured for different time in 2 × 105/mL. After the co-culture for 24 h or other specific period of time, the co-culture cell-free supernatants and two chambers of cells were collected respectively. In order to detect the level of CCL2 in Cal-27 cells and THP-1-derived macrophages or in the supernatants of co-culture system, as shown in Fig. 2a and b, Cal-27 cells and THP-1-derived macrophages were co-cultured for 24 h, thereafter separated and cultured alone in 24-well plate with 1 mL pre-warmed fresh medium for another 24 h, then cells and cell-free supernatants were collected respectively. In order to detect CCL2 function in modulate the cytokines expression of THP-1-derived macrophages in co-culture system, as shown in Figs 4c and 5c, the co-culture system added 10 μg/mL anti-CCL2 neutralizing mAb for 24 hours, and then the cell-free supernatants and cells were obtained.
shRNA transient transfection
The pGPU6/GFP/Neo vector containing Kif4A-targeting shRNA (siKif4A) sequences and a nonspecific shRNA (scr) as negative control were purchased from Shanghai GeneChem Corporation (Shanghai, China). THP-1-derived macrophages and Cal-27 cells were seeded in 6-well culture plates with 60% confluence before transfection. Cells then were transfected with siKif4A or scr (2 µg plasmid) by 5 µL Lipofectamine™ 2000 (Invitrogen, Carlsbad, USA) following the manufacturer’s instructions. Flow cytometry analysis showed that transfection efficiency at 48 h was more than 90%.
Cell migration assay
Cell migration assay was carried out using 24-well transwell inserts (8 μm pore size membrane, BD Biosciences, Franklin Lakes, NJ, USA) following to the manufacturer’s instructions. In brief, THP-1-derived macrophages (1 × 105 cells/well) or Cal-27 cells (1 × 105 cells/well) were placed into the upper chamber of transwell inserts with 100 μL of serum-free medium. THP-1-derived macrophages (1 × 105 cells/well, for migration assay of macrophages) or Cal-27 cells (1 × 105 cells/well, for migration assay of cancer cells) in 600 μL RPMI 1640 medium containing 10% FBS were added into the lower chambers of the transwell plate correspondingly, 600 μL RPMI 1640 medium containing 10% FBS in lower chambers without cells as medium control. In some cases, CCL2 neutralizing antibody and isotype antibodies (10 μg/mL) were added into supernatant in lower chamber before incubation. Cells were incubated at 37 °C in 5% CO2 for 24 h. The migrated cells on the lower side of the membrane were fixed by 10% formalin and stained with eosin. Five random fields of each well were photographed and counted.
Flow cytometric analysis
To detect the expression of CCR2 in THP-1-derived macrophages from co-culture system, cells were stained with fluorescence-conjugated anti-human mAbs CCR2-PE and the isotype antibody respectively for 30 minutes in the dark at room temperature. Cells acquisition was performed using a FACS Calibur flow cytometer (BD Biosciences, CA, USA) and data were analyzed via CellQuest software program of the FACS Calibur system (BD Biosciences, CA, USA).
Chemokine analysis
The supernates were obtained from different culture groups and centrifuged at 2000 g, then stored in liquid nitrogen immediately until use. The amount of human chemokine, including CCL2, CCL7 in the co-culture system and monoculture groups supernatants were measured by enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, UK) according to the manufacturer’s guidelines. All measurements were performed in triplicate to avoid technical error and intra-assay variants
Real-time quantitative RT-PCR (RTQ-PCR)
Total RNA of different culture groups was isolated with the Qiagen RNeasy mini kit (Hilden, Germany) according to the manufacturer’s instructions. RNA was reverse-transcribed to cDNA by RevertAid M-MuLV Reverse Transcriptase (Fermentas, Burlington, Ontario, Canada) with Oligo dT primers (Invitrogen, Carlsbad, CA, USA). Amplification of targeting gene were carried out by RTQ-PCR using the SYBR Green I (Bio-Rad, München, Germany) method in 10 μL reactions (5 μL of × 2 TaqMan Master mix, 1 μL each primer, 1 μL cDNA, 2 μL H2O). All procedures were conducted according to the manufacturer’s instructions. RTQ-PCR was performed using the LightCycler 2.0 Instrument (Roche, Penzberg, Germany). Relative gene expression was normalized to the expression of GAPDH mRNA and expressed as fold change for each relative gene reaction among the samples.
Western blotting
Cell lysates containing equal amounts of total proteins from each group cells was separated on an 8% sodium dodecyl sulfate-polyacrylamide gel for Kif4A, CCR2, STAT-3, pSTAT-3, β-actin and GAPDH, respectively. The proteins were transferred to polyvinyl difluoride membranes (Millipore, USA), which were blocked with TBST (Tris-buffered saline, 0.1% Tween 20) containing 5% nonfat dried milk and immunoblotted with appropriate primary antibodies overnight at 4 °C. Membranes were washed with TBST for 3 times; the bounded antibodies were visualized using peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology, CA, USA) for 1 h. Results were visualized by chemiluminescence detection using an ECL Kit (Millipore, USA) on Image Station 4000 MM Pro (Carestream Health Inc., USA).
Immunohistochemistry (IHC)
4-μm-thick sequential histological tumor sections were obtained from a representative formalin-fixed, paraffin-embedded OSCC tumor block and used for IHC analysis. IHC was performed using an automated staining system with antibodies against Kif4A (GTX115759, dilution 1:200; Gene Tex, USA), CD68 (lone KP1, dilution 1:100; ZM-006, ZSGB-bio, Beijng, China). Expression of all of the markers in cells was detected using a Novocastra Bond Polymer Refine Detection kit (PV9000, ZSGB-bio, Beijng, China) with a diaminobenzidinereaction to detect antibody labeling and hematoxylin counterstaining. Samples were viewed under the Olympus IX81 microscope.
Statistical analysis
Prism 5.0 (GraphPad Software, CA, USA) was used for Statistical analysis. First, we used Shapiro-Wilk test to analysis normality of the data. If data were normally distributed, we used the 2-tailed Student’s t-test and Pearson’s test. Non-normally distributed data were analyzed by Mann-Whitney U-test. For all statistical tests, p values < 0.05 were considered statistically significant. Data from independent experiments were presented as the mean values ± standard error of the mean (mean ± SEM) for percentages.
Electronic supplementary material
Acknowledgements
This study was supported by National Natural Science Foundation of China (grant nos 31470885, 31270971 and 81271105) and Natural Science Foundation of Shandong Province (grant no. 2010GSF10273)
Author Contributions
Y.Z. designed and carried out main experimental work and wrote the main manuscript text. L.Z., X.X.J. and C.L. acquired and analyzed data. S.H.L. designed the work and analyzed data. D.V.Q., K.T.W. carried out experimental work. F.C.W. revised the manuscript. X.Q. designed the work, and revised the manuscript. All authors reviewed the manuscript.
Competing Interests
The authors declare that they have no competing interests.
Footnotes
Electronic supplementary material
Supplementary information accompanies this paper at doi:10.1038/s41598-017-02261-7
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2006;102:67–76. doi: 10.1016/j.tripleo.2005.07.038. [DOI] [PubMed] [Google Scholar]
- 2.Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. The New England journal of medicine. 2001;345:1890–1900. doi: 10.1056/NEJMra001375. [DOI] [PubMed] [Google Scholar]
- 3.Hu Y, et al. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma. Journal of experimental & clinical cancer research: CR. 2016;35:12. doi: 10.1186/s13046-015-0281-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Weber M, et al. Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas–an immunohistochemical study. British journal of cancer. 2015;113:510–519. doi: 10.1038/bjc.2015.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer research. 2006;66:605–612. doi: 10.1158/0008-5472.CAN-05-4005. [DOI] [PubMed] [Google Scholar]
- 6.Weber M, et al. Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas. Oral oncology. 2016;52:75–84. doi: 10.1016/j.oraloncology.2015.11.001. [DOI] [PubMed] [Google Scholar]
- 7.He KF, et al. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. BioMed research international. 2014;2014:838632. doi: 10.1155/2014/838632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wu MH, et al. Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression. Clinical cancer research: an official journal of the American Association for Cancer Research. 2011;17:1306–1316. doi: 10.1158/1078-0432.CCR-10-1824. [DOI] [PubMed] [Google Scholar]
- 9.Tsuyada A, et al. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer research. 2012;72:2768–2779. doi: 10.1158/0008-5472.CAN-11-3567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zhang, Y. et al. Human trophoblast cells induced MDSCs from peripheral blood CD14 myelomonocytic cells via elevated levels of CCL2. Cellular & molecular immunology (2015). [DOI] [PMC free article] [PubMed]
- 11.Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nature immunology. 2001;2:102–107. doi: 10.1038/84205. [DOI] [PubMed] [Google Scholar]
- 12.Rath O, Kozielski F. Kinesins and cancer. Nature reviews. Cancer. 2012;12:527–539. doi: 10.1038/nrc3310. [DOI] [PubMed] [Google Scholar]
- 13.Bernasconi P, et al. The kinesin superfamily motor protein KIF4 is associated with immune cell activation in idiopathic inflammatory myopathies. Journal of neuropathology and experimental neurology. 2008;67:624–632. doi: 10.1097/NEN.0b013e318177e5fd. [DOI] [PubMed] [Google Scholar]
- 14.Narayan G, et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes, chromosomes & cancer. 2007;46:373–384. doi: 10.1002/gcc.20418. [DOI] [PubMed] [Google Scholar]
- 15.Taniwaki M, et al. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2007;13:6624–6631. doi: 10.1158/1078-0432.CCR-07-1328. [DOI] [PubMed] [Google Scholar]
- 16.Minakawa Y, et al. Kinesin family member 4A: a potential predictor for progression of human oral cancer. PloS one. 2013;8:e85951. doi: 10.1371/journal.pone.0085951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zhang J, Patel L, Pienta KJ. CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. Cytokine & growth factor reviews. 2010;21:41–48. doi: 10.1016/j.cytogfr.2009.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lawrence CJ, et al. A standardized kinesin nomenclature. The Journal of cell biology. 2004;167:19–22. doi: 10.1083/jcb.200408113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Miki H, Setou M, Kaneshiro K, Hirokawa N. All kinesin superfamily protein, KIF, genes in mouse and human. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:7004–7011. doi: 10.1073/pnas.111145398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhu C, Jiang W. Cell cycle-dependent translocation of PRC1 on the spindle by Kif4 is essential for midzone formation and cytokinesis. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:343–348. doi: 10.1073/pnas.0408438102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Mazumdar M, et al. Tumor formation via loss of a molecular motor protein. Current biology: CB. 2006;16:1559–1564. doi: 10.1016/j.cub.2006.06.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Gao J, et al. Overexpression of chromokinesin KIF4 inhibits proliferation of human gastric carcinoma cells both in vitro and in vivo. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2011;32:53–61. doi: 10.1007/s13277-010-0090-0. [DOI] [PubMed] [Google Scholar]
- 23.Ni YH, et al. Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36:5291–5298. doi: 10.1007/s13277-015-3189-5. [DOI] [PubMed] [Google Scholar]
- 24.Chiu KC, et al. Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma. Oral oncology. 2015;51:683–689. doi: 10.1016/j.oraloncology.2015.04.004. [DOI] [PubMed] [Google Scholar]
- 25.Barros MH, Segges P, Vera-Lozada G, Hassan R, Niedobitek G. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival. PloS one. 2015;10:e0124531. doi: 10.1371/journal.pone.0124531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Incio, J. et al. PlGF/VEGFR-1 signaling promotes macrophage polarization and accelerated tumor progression in obesity. Clinical cancer research: an official journal of the American Association for Cancer Research (2016). [DOI] [PMC free article] [PubMed]
- 27.Craig MJ, Loberg RD. CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases. Cancer metastasis reviews. 2006;25:611–619. doi: 10.1007/s10555-006-9027-x. [DOI] [PubMed] [Google Scholar]
- 28.Bonapace L, et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature. 2014;515:130–133. doi: 10.1038/nature13862. [DOI] [PubMed] [Google Scholar]
- 29.Loberg RD, et al. CCL2 is a potent regulator of prostate cancer cell migration and proliferation. Neoplasia. 2006;8:578–586. doi: 10.1593/neo.06280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lu Y, et al. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. The Prostate. 2006;66:1311–1318. doi: 10.1002/pros.20464. [DOI] [PubMed] [Google Scholar]
- 31.Chikamatsu K, et al. Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck. Cancer science. 2012;103:976–983. doi: 10.1111/j.1349-7006.2012.02248.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zhao P, et al. Response gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4. Cellular & molecular immunology. 2015;12:692–699. doi: 10.1038/cmi.2014.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.